Epidemiology of benign breast disease, with special attention to histologic types.

Benign breast disease deserves attention because of its high prevalence, its impact on women's quality of life, and, for some histologic types, its cancerous potential. Identification of risk factors for benign breast disease could improve our understanding of its etiology and pathogenesis and help to define preventive strategies. Benign breast disease has been extensively studied, and this wealth of literature warrants periodic reevaluation. This paper both updates and extends a previous review by Ernster (1) by summarizing accumulated information on the relation of benign breast disease to smoking, methylxanthines, and diet that was not covered in that earlier review. It does not, however, include a section on the relation between benign breast disease and breast cancer, a topic recently reviewed by Bodian (2). We have also attempted to consolidate the wide range of terms used to describe the histologic manifestations of this disease.

[1]  T. Rohan,et al.  Dietary fiber and risk of benign proliferative epithelial disorders of the breast , 1995, International journal of cancer.

[2]  and Oral Contraceptives , 1995 .

[3]  P. Ghadirian,et al.  Nutritional profile of women with fibrocystic breast disease. , 1993, International journal of epidemiology.

[4]  C. Bodian Benign breast diseases, carcinoma in situ, and breast cancer risk. , 1993, Epidemiologic reviews.

[5]  P. Ghadirian,et al.  Case-control study of fibrocystic breast disease. , 1993, Revue d'epidemiologie et de sante publique.

[6]  G R Howe,et al.  Risk factors for fibroadenoma: a case-control study in Australia. , 1992, American journal of epidemiology.

[7]  H. Le Benign breast disorders: the clinician's view. , 1992 .

[8]  L. Hughes Benign breast disorders: the clinician's view. , 1992, Cancer detection and prevention.

[9]  D. Ingram,et al.  The role of diet in the development of breast cancer: a case-control study of patients with breast cancer, benign epithelial hyperplasia and fibrocystic disease of the breast. , 1991, British Journal of Cancer.

[10]  C. la Vecchia,et al.  Smoking habits and risk of benign breast disease. , 1991, International journal of epidemiology.

[11]  A. Howell,et al.  Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast , 1991, International journal of cancer.

[12]  J. Potter,et al.  A case-control study of diet and benign proliferative epithelial disorders of the breast. , 1990, Cancer research.

[13]  P. Band,et al.  Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer. , 1990, American journal of epidemiology.

[14]  A. Simard,et al.  Nutrition and lifestyle factors in fibrocystic disease and cancer of the breast. , 1990, Cancer detection and prevention.

[15]  J. Baron,et al.  Cigarette smoking and benign proliferative epithelial disorders of the breast in women: a case-control study. , 1989, Journal of epidemiology and community health.

[16]  K. McPherson,et al.  Oral contraceptive use influences resting breast proliferation. , 1989, Human pathology.

[17]  T. Rohan,et al.  Methylxanthines and benign proliferative epithelial disorders of the breast in women. , 1989, International journal of epidemiology.

[18]  D. Ingram,et al.  Obesity and breast disease. The role of the female sex hormones , 1989, Cancer.

[19]  B. Modan,et al.  Nutritional factors associated with benign breast disease etiology: a case-control study. , 1989, The American journal of clinical nutrition.

[20]  I. Ellis,et al.  In situ carcinoma of the breast. , 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  A. Morrison,et al.  Histologic and mammographic specificity of risk factors for benign breast disease , 1989, Cancer.

[22]  T. Rohan,et al.  Alcohol consumption and risk of benign proliferative epithelial disorders of the breast in women , 1989, International journal of cancer.

[23]  S. Schnitt,et al.  In situ carcinoma of the breast. , 1989, Annual review of medicine.

[24]  J. Kelsey,et al.  Fibroadenoma and the use of exogenous hormones. A case-control study. , 1988, American journal of epidemiology.

[25]  C. Alderman Benign breast disease. , 1988, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[26]  T. Anderson,et al.  Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. , 1988, The American journal of pathology.

[27]  R. Mansel,et al.  ABERRATIONS OF NORMAL DEVELOPMENT AND INVOLUTION (ANDI): A NEW PERSPECTIVE ON PATHOGENESIS AND NOMENCLATURE OF BENIGN BREAST DISORDERS , 1987, The Lancet.

[28]  C. Key,et al.  Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study , 1987, Cancer.

[29]  J. A. Andersen,et al.  Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. , 1987, British Journal of Cancer.

[30]  V. Ernster,et al.  Influence of pregnancy and lactation on serum and breast fluid estrogen levels: Implications for breast cancer risk , 1987, International journal of cancer.

[31]  V. Ernster,et al.  Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. , 1987, Journal of the National Cancer Institute.

[32]  J. Kelsey,et al.  Estrogen replacement therapy and fibrocystic breast disease. , 1987, American journal of preventive medicine.

[33]  J. Russo,et al.  Influence of age and gland topography on cell kinetics of normal human breast tissue. , 1987, Journal of the National Cancer Institute.

[34]  A. Walker,et al.  Conjugated estrogens and fibrocystic breast disease. , 1986, American Journal of Epidemiology.

[35]  Godfrey Se Is 'fibrocystic disease' of the breast precancerous? , 1986, Archives of pathology & laboratory medicine.

[36]  R. Frisch,et al.  Lower prevalence of benign diseases of the breast and benign tumours of the reproductive system among former college athletes compared to non-athletes. , 1986, British Journal of Cancer.

[37]  J. Kelsey,et al.  Cigarette smoking and benign breast disease. , 1985, Journal of epidemiology and community health.

[38]  C. Alpers,et al.  The prevalence of carcinoma in situ in normal and cancer-associated breasts. , 1985, Human pathology.

[39]  J. Kelsey,et al.  Risk factors for fibrocystic breast disease and its histopathologic components. , 1985, Journal of the National Cancer Institute.

[40]  David L. Page,et al.  Atypical hyperplastic lesions of the female breast. A long‐term follow‐up study , 1985, Cancer.

[41]  C. la Vecchia,et al.  Benign breast disease and consumption of beverages containing methylxanthines. , 1985, Journal of the National Cancer Institute.

[42]  T. Rohan,et al.  The patho‐epidemiology of benign proliferative epithelial disorders of the female breast , 1985, The Journal of pathology.

[43]  E. Ron,et al.  A case-control study of caffeine and methylxanthines in benign breast disease. , 1985, JAMA.

[44]  T. K. Hunt,et al.  Vitamin E and benign breast "disease": a double-blind, randomized clinical trial. , 1985, Surgery.

[45]  J. Kelsey,et al.  An epidemiologic study of fibrocystic breast disease with reference to ductal epithelial atypia. , 1985, American journal of epidemiology.

[46]  G. Beck,et al.  Estrogen replacement therapy and fibrocystic breast disease in postmenopausal women. , 1985, American journal of epidemiology.

[47]  R. Brown,et al.  Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women. , 1985, British Journal of Cancer.

[48]  W D Dupont,et al.  Risk factors for breast cancer in women with proliferative breast disease. , 1985, The New England journal of medicine.

[49]  R. London,et al.  The Effect of Vitamin E on Mammary Dysplasia: A Double‐Blind Study , 1985, Obstetrics and gynecology.

[50]  R. Hoover,et al.  Estrogen replacement therapy and benign breast disease. , 1984, Journal of the National Cancer Institute.

[51]  J. Kelsey,et al.  Exogenous hormone use and fibrocystic breast disease by histopathologic component , 1984, International journal of cancer.

[52]  M. King,et al.  Risk factors for benign breast disease: a case-control study of discordant twins. , 1984, American journal of epidemiology.

[53]  C. la Vecchia,et al.  Oral contraceptives and benign breast disease: a case-control study. , 1984, American journal of obstetrics and gynecology.

[54]  C. la Vecchia,et al.  Risk factors for pathologically confirmed benign breast disease. , 1984, American journal of epidemiology.

[55]  J. Kelsey,et al.  Oral contraceptive use and fibrocystic breast disease among pre- and postmenopausal women. , 1984, American journal of epidemiology.

[56]  J. Kelsey,et al.  Caffeine consumption and fibrocystic breast disease: a case-control epidemiologic study. , 1984, Journal of the National Cancer Institute.

[57]  B. Macmahon,et al.  Age at first birth and breast atypia , 1984, International journal of cancer.

[58]  W. Willett,et al.  Diet and cancer--an overview (second of two parts). , 1984, The New England journal of medicine.

[59]  B. Macmahon,et al.  Oral contraceptive use and fibrocystic breast disease of different histologic classifications. , 1984, Journal of the National Cancer Institute.

[60]  M. Nielsen,et al.  Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women , 1984, Cancer.

[61]  J. Azzopardi Benign and malignant proliferative epithelial lesions of the breast; a review. , 1983, European journal of cancer & clinical oncology.

[62]  S. Duffy,et al.  Risk factors relevant to cystic breast disease: a case-control study. , 1983, Journal of epidemiology and community health.

[63]  J. Kelsey,et al.  Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology. , 1983, Journal of the National Cancer Institute.

[64]  R. Brown,et al.  Incidence of perilobular hemangioma in the female breast. , 1983, Archives of pathology & laboratory medicine.

[65]  Leon Speroff,et al.  Clinical gynecologic endocrinology and infertility , 1983 .

[66]  S. Love,et al.  Fibrocystic Disease of the Breast — A Nondisease? , 1982 .

[67]  B. Armstrong,et al.  The comparative epidemiology of benign breast lumps and breast cancer in Western Australia , 1982, International journal of cancer.

[68]  S. Graham,et al.  Caffeine consumption and benign breast disease: a case-control comparison. , 1982, American journal of public health.

[69]  T. K. Hunt,et al.  Effects of caffeine-free diet on benign breast disease: a randomized trial. , 1982, Surgery.

[70]  D. Glebatis "Risk factors for benign breast disease". , 1982, American journal of epidemiology.

[71]  S. Love,et al.  Sounding board. Fibrocystic "disease" of the breast--a nondisease? , 1982, The New England journal of medicine.

[72]  K. Rothman,et al.  Coffee and tea consumption and breast disease. , 1981, Surgery.

[73]  M. Hakama,et al.  Independent risk factors of benign and malignant breast lesions. , 1981, American Journal of Epidemiology.

[74]  H. Abou-Issa,et al.  Clinical and biochemical studies on methylxanthine-related fibrocystic breast disease. , 1981, Surgery.

[75]  S. Gart,et al.  Measuring the effect of caffeine restriction on fibrocystic breast disease: the role of graphic stress telethermometry as an objective monitor of disease. , 1981, The Journal of reproductive medicine.

[76]  J. Elwood,et al.  Risk factors for benign breast disease: a 30-year cohort study. , 1981, Canadian Medical Association journal.

[77]  V. Ernster The epidemiology of benign breast disease. , 1981, Epidemiologic reviews.

[78]  E. Cornish METHYLXANTHINES AND BENIGN BREAST DISEASE , 1979, The Medical journal of Australia.

[79]  Webster Dj,et al.  Caffeine, cyclic nucleotides, and breast disease. , 1979, Surgery.

[80]  H. Freeman,et al.  Analysis of benign breast lesions in blacks. , 1979, American journal of surgery.

[81]  R. Sitruk-Ware,et al.  Benign Breast Disease I: Hormonal Investigation , 1979, Obstetrics and gynecology.

[82]  J. Lindtner,et al.  An epidemiologic study of breast cancer and benign breast neoplasias in relation to the oral contraceptive and estrogen use. , 1979, European journal of cancer.

[83]  A. Lees,et al.  Oral contraceptives and breast disease in premenopausal northern albertan women , 1978, International journal of cancer.

[84]  D. Page,et al.  Relation between component parts of fibrocystic disease complex and breast cancer. , 1978, Journal of the National Cancer Institute.

[85]  J. Tonascia,et al.  Benign and malignant breast tumours: epidemiological similarities. , 1978, International journal of epidemiology.

[86]  J. Kelsey,et al.  Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia. , 1978, The New England journal of medicine.

[87]  P. Cole,et al.  Incidence rates and risk factors of benign breast neoplasms. , 1978, American journal of epidemiology.

[88]  G. Stemmermann,et al.  Volume and hyperplastic lesions of breasts of Japanese women in Hawaii and Japan. , 1978, Preventive medicine.

[89]  B. Macmahon,et al.  Oral contraceptive use: association with frequency of hospitalization and chronic disease risk indicators. , 1978, American journal of public health.

[90]  J. Kelsey,et al.  Oral contraceptives and breast disease. An epidemiological study. , 1978, American journal of epidemiology.

[91]  J. Tonascia,et al.  Epidemiologic characteristics of benign breast disease. , 1977, American journal of epidemiology.

[92]  I. Mowszowicz,et al.  Inadequate corpus luteal function in women with benign breast diseases. , 1977, The Journal of clinical endocrinology and metabolism.

[93]  J. Meyer Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones. , 1977, Human pathology.

[94]  G. Comstock,et al.  Benign breast tumor and estrogenic hormones: a population-based retrospective study. , 1976, American journal of epidemiology.

[95]  B. Macmahon,et al.  Oral contraceptives and reduced risk of benign breast diseases. , 1976, The New England journal of medicine.

[96]  R. Paffenbarger,et al.  Oral contraceptives as related to cancer and benign lesions of the breast. , 1975, Journal of the National Cancer Institute.

[97]  H M Jensen,et al.  An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. , 1975, Journal of the National Cancer Institute.

[98]  J. Kelsey,et al.  A case-control study of the epidemiology of benign breast diseases with reference to oral contraceptive use. , 1974, International journal of epidemiology.

[99]  M. Chipman,et al.  Breast feeding, family history, and breast disease. , 1974, American journal of epidemiology.

[100]  Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. , 1974, The New England journal of medicine.

[101]  K. Prechtel,et al.  Der Einfluß oraler Steroidkontrazeptiva auf das Fibroadenom der Mamma* , 1973 .

[102]  J. Tonascia,et al.  Epidemiology of benign breast lesions: lack of association with oral contraceptive use. , 1973, The New England journal of medicine.

[103]  B. Rush,et al.  Mammary duct proliferation in the elderly. A histopathologic study , 1973, Cancer.

[104]  M. Levy,et al.  Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Report from the Boston Collaborative Drug Surveillance Programme. , 1973, Lancet.

[105]  R. Fechner Benign breast disease in women on estrogen therapy. A pathologic study , 1972, Cancer.

[106]  R. Doll,et al.  Investigation of the possible relationship between oral contraceptives and benign and malignant breast disease , 1971, Cancer.

[107]  H. Taylor Oral contraceptives and pathologic changes in the breast , 1971, Cancer.

[108]  R. Tank,et al.  Multiple breast fibroadenomas in women on hormonal contraceptives. , 1971, The New England journal of medicine.

[109]  R. Fechner Fibrocystic disease in women receiving oral contraceptive hormones , 1970, Cancer.

[110]  R. Fechner Fibroadenomas in patients receiving oral contraceptives: a clinical and pathologic study. , 1970, American journal of clinical pathology.

[111]  N. Mottet,et al.  Florid breast fibroadenomas in patients taking hormonal oral contraceptives. , 1968, American journal of clinical pathology.

[112]  L. Humphrey,et al.  Histologic changes in clinically normal breasts at postmortem examination. , 1966, Archives of surgery.

[113]  John B. Davis,et al.  Cystic disease of the breast: Relationship to carcinoma , 1964, Cancer.

[114]  A. Sandison An autopsy study of the adult human breast: with special reference to proliferative epithelial changes of importance in the pathology of the breast. , 1962, National Cancer Institute monograph.

[115]  Clagett Ot,et al.  Incidence in Normal Breasts of Features Associated with Chronic Cystic Mastitis , 1957 .

[116]  P. Sloss,et al.  Incidence in normal breasts of features associated with chronic cystic mastitis. , 1957, The American journal of pathology.

[117]  J. Pickren,et al.  Incidence of chronic cystic disease in so‐called “normal breasts”. A study based on 225 postmortem examinations , 1951 .

[118]  F. W. Foote,et al.  COMPARATIVE STUDIES OF CANCEROUS VERSUS NONCANCEROUS BREASTS , 1945, Annals of surgery.

[119]  E T BELL,et al.  The Diseases of the Breast , 1925, Nature.